Researchers propose a stopgap measure to help Covid-19 patients in acute respiratory distress: a drug called tissue plasminogen activator, which dissolves blood clots.
Click here for original story, COVID-19: Stopgap measure to treat respiratory distress
Source: ScienceDaily